Summary
The product Aromamed 25, manufactured by Deus Medical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number DM09106, was submitted by DEUSPOWER.SHOP and analyzed by Janoshik Analytical. The analysis confirmed the presence of Exemestane, with measured concentrations of 24.93 mg and 24.74 mg in two separate pills, closely aligning with the labeled 25 mg dosage.
The testing process began on 13 November 2020, with the sample received on 18 November 2020, and analysis completed on 20 November 2020. While the results confirm accurate dosing, the involvement of a reseller in the submission process raises questions about broader product consistency across different batches. Independent third-party testing remains crucial to further validate these findings.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Aromamed 25
- Active Ingredient: Exemestane
- Batch Number: DM09106 (Manufactured: 10/2020)
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #09128
- Testing Ordered: 13 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
- Specification: 25 mg (as stated on the label)
- Measured Concentration: 24.93 mg & 24.74 mg
- Accuracy: 99.72% of the label claim
- Variance: – 0.28% deviation
Verification Details
- Verification URL: https://janoshik.com/tests/09128_WVWUC3ZCDIB4
Evaluation of Reseller-Submitted Testing
While the results demonstrate strong accuracy in the tested batch, it’s essential to recognize that this sample was submitted and paid for by DEUSPOWER.SHOP, a reseller. Resellers may selectively submit high-quality batches for testing, which may not fully represent the overall consistency of the product across different batches.
Although Janoshik Analytical is recognized for its transparency and reliability, comprehensive validation requires independent third-party testing across multiple batches to ensure product uniformity. Consumers should be aware of this potential bias and consider additional sources of verification when assessing product quality.
Conclusion
The analysis confirms that Aromamed 25 by Deus Medical is accurately dosed, with Exemestane levels closely matching the label claim. The slight deviation of 1.04% falls within acceptable limits, indicating strong manufacturing quality for this batch.
However, given the nature of reseller-submitted testing, further independent analysis is recommended to verify consistency across different batches. Buyers should remain informed about potential variances in product quality over time.
This report is published as an educational resource to help consumers make safer and more informed choices regarding Exemestane-containing products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside independent results.
Readers are encouraged to use this information responsibly and verify product quality through multiple independent sources where possible.
